keyword
https://read.qxmd.com/read/38554764/editorial-ex-vivo-onco-testis-microdissection
#1
EDITORIAL
Stanton Charles Honig
No abstract text is available yet for this article.
March 28, 2024: Fertility and Sterility
https://read.qxmd.com/read/38403108/ex-vivo-microscopic-onco-testicular-sperm-extraction-step-by-step-surgical-technique-at-time-of-radical-orchiectomy
#2
JOURNAL ARTICLE
Christopher K Villota, Sean W Hou, Clark Judge, Scott Eggener, Gladell Paner, Omer A Raheem
OBJECTIVE: To demonstrate the intraoperative surgical techniques required for a simultaneous radical orchiectomy and microscopic onco-testicular sperm extraction (m-OncoTESE) in step- by-step fashion. DESIGN: Video presentation. SETTING: University hospital (University of Chicago). PATIENT(S): A 37-year-old male (status post right orchiectomy at another institution for stage II-C testicular seminoma with positive preoperative tumor markers) was referred for contralateral orchiectomy for multifocal left testis mass and fertility preservation...
February 23, 2024: Fertility and Sterility
https://read.qxmd.com/read/37512038/onco-tese-testicular-sperm-extraction-insights-from-a-tertiary-center-and-comprehensive-literature-analysis
#3
JOURNAL ARTICLE
Lorenzo Cirigliano, Marco Falcone, Murat Gül, Mirko Preto, Carlo Ceruti, Natalia Plamadeala, Federica Peretti, Ilaria Ferro, Martina Scavone, Paolo Gontero
Background and Objectives : The peak of incidence of testicular cancer (TC) occurs among individuals in their reproductive age, emphasizing the importance of fertility preservation as an integral aspect of disease management. Sperm cryopreservation performed before orchiectomy is ineffective in azoospermic men, necessitating alternative approaches such as microdissection testicular sperm extraction (mTESE) at the time of orchiectomy (onco-mTESE) to obtain viable sperm. This study presents the findings from our institution's experience with onco-mTESE and critically discusses our results in light of the existing body of literature...
June 29, 2023: Medicina
https://read.qxmd.com/read/37302780/laparoscopic-oocyte-retrieval-for-fertility-preservation-in-a-patient-with-squamous-cell-carcinoma-of-the-vagina
#4
JOURNAL ARTICLE
Pierluigi Giampaolino, Antonio Mercorio, Paolo Serafino, Giuseppe Gabriele Iorio, Cira Buonfantino, Giuseppe Bifulco, Attilio Di Spiezio Sardo, Jose Carugno, Carlo Alviggi
OBJECTIVE: To describe a feasible fertility preservation strategy in a woman with vaginal carcinoma. DESIGN: Video case report demonstrating the diagnostic work-up and laparoscopic oocyte retrieval performed under regional anesthesia. SETTING: University tertiary care hospital. PATIENT(S): A 35-year-old nulliparous woman presented with vaginal bleeding and foul-smelling vaginal discharge. After a comprehensive diagnostic work-up, a final diagnosis of squamous cell carcinoma of the vagina stage II (Federation International Obstetrics and Gynecology classification) was made...
September 2023: Fertility and Sterility
https://read.qxmd.com/read/36324079/an-evaluation-of-the-population-characteristics-semen-quality-and-utilization-status-of-autologous-sperm-cryopreservation-and-fertility-preservation-in-for-662-patients-a-6-year-monocentric-retrospective-study
#5
JOURNAL ARTICLE
Wenhao Tang, Chenyao Deng, Jiangman Gao, Senlin Tian, Nan Wei, Bin Li, Jianfei Song, Liang Zhang, Han Wu, Hui Jiang
BACKGROUND: Sperm cryopreservation is an effective method of fertility preservation for disease-related and social sperm freezing. In total, 662 subjects (range: 15-65 years-of-age; mean: 33.49 ± 8.79 years-of-age) were included in this study to investigate the population characteristics, semen quality, and usage of autologous sperm preservation patients in Beijing. Of these, 351 were cancer patients (53.02%, 31.14 ± 7.32 years-of-age) and 311 were non-cancer patients (46...
November 3, 2022: Basic and Clinical Andrology
https://read.qxmd.com/read/35342935/white-paper-oncofertility-in-pediatric-patients-with-wilms-tumor
#6
JOURNAL ARTICLE
M E Madeleine van der Perk, Nicholas G Cost, Annelies M E Bos, Robert Brannigan, Tanzina Chowdhury, Andrew M Davidoff, Najat C Daw, Jeffrey S Dome, Peter Ehrlich, Norbert Graf, James Geller, John Kalapurakal, Kathleen Kieran, Marcus Malek, Mary F McAleer, Elizabeth Mullen, Luke Pater, Angela Polanco, Rodrigo Romao, Amanda F Saltzman, Amy L Walz, Andrew D Woods, Marry M van den Heuvel-Eibrink, Conrad V Fernandez
The survival of childhood Wilms tumor is currently around 90%, with many survivors reaching reproductive age. Chemotherapy and radiotherapy are established risk factors for gonadal damage and are used in both COG and SIOP Wilms tumor treatment protocols. The risk of infertility in Wilms tumor patients is low but increases with intensification of treatment including the use of alkylating agents, whole abdominal radiation or radiotherapy to the pelvis. Both COG and SIOP protocols aim to limit the use of gonadotoxic treatment, but unfortunately this cannot be avoided in all patients...
September 15, 2022: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/34813838/onco-testicular-sperm-extraction-oncotese-a-contemporary-concept-review-and-report-of-australian-sperm-retrieval-rates-and-fertility-outcomes
#7
JOURNAL ARTICLE
Gideon Adam Blecher, Eric Chung, Darren Katz, Shannon Hee Kyung Kim, John Bailie
OBJECTIVE: To assess sperm retrieval rates of Onco-Testicular Sperm Extraction (oncoTESE) in men with testicular tumors and coexisting severe spermatogenic impairment. METHODS: Multi-centre Australian wide retrospective review of oncoTESE procedures performed within the last 10 years. Patients were postpubertal adults having a testicular tumor requiring orchidectomy, with severe oligozoospermia or nonobstructive azoospermia. Ipsilateral testicular sperm extraction was performed following radical inguinal orchidectomy...
February 2022: Urology
https://read.qxmd.com/read/34193292/onco-fertility-and-personalized-testing-for-potential-for-loss-of-ovarian-reserve-in-patients-undergoing-chemotherapy-proposed-next-steps-for-development-of-genetic-testing-to-predict-changes-in-ovarian-reserve
#8
REVIEW
Bei Sun, John Yeh
Women of reproductive age undergoing chemotherapy face the risk of irreversible ovarian insufficiency. Current methods of ovarian reserve testing do not accurately predict future reproductive potential for patients undergoing chemotherapy. Genetic markers that more accurately predict the reproductive potential of each patient undergoing chemotherapy would be critical tools that would be useful for evidence-based fertility preservation counselling. To assess the possible approaches to take to develop personalized genetic testing for these patients, we review current literature regarding mechanisms of ovarian damage due to chemotherapy and genetic variants associated with both the damage mechanisms and primary ovarian insufficiency...
June 30, 2021: Fertility Research and Practice
https://read.qxmd.com/read/33864966/safety-of-surgical-fertility-preservation-procedures-in-children-prior-to-hematopoietic-stem-cell-transplant
#9
JOURNAL ARTICLE
Katelynn Brodigan, Malika Kapadia, A Lindsay Frazier, Marc R Laufer, Richard Yu, Brent R Weil, Elizabeth S Ginsburg, Christine Duncan, Leslie Lehmann
BACKGROUND: Long-term survival following hematopoietic stem cell transplant (HSCT) in childhood continues to improve and patients are thus increasingly faced with the late effects of treatment. Infertility is very common for both males and females following HSCT and is one of the most distressing sequelae. Adoption and surrogate egg or sperm donation are possibilities for some patients but post-HSCT reversal of gonadal failure is not possible. We have recently initiated an onco-fertility program with a dedicated practitioner with specific expertise in this area...
April 14, 2021: Transplantation and cellular therapy
https://read.qxmd.com/read/33458904/can-some-anticancer-treatments-preserve-the-ovarian-reserve
#10
REVIEW
Nicolas Vallet, Nicolas Boissel, Elisabeth Elefant, Florian Chevillon, Hélène Pasquer, Charlotte Calvo, Nathalie Dhedin, Catherine Poirot
BACKGROUND: Preventing premature ovarian failure (POF) is a major challenge in oncology. With conventional regimens, cytotoxicity-associated POF involves primordial follicles (PF) pool depletion by apoptosis or overactivation mechanisms, notably mediated by the ABL/TAp63 and PI3K/Akt/mTOR pathways. New anticancer treatments have been designed to target pathways implicated in tumor growth. Although concerns regarding fertility arise with these targeted therapies, we hypothesized that targeted therapies may exert off-tumor effects on PF that might delay POF...
June 2021: Oncologist
https://read.qxmd.com/read/32330263/deficiency-of-the-onco-mirna-cluster-mir-106b%C3%A2-25-causes-oligozoospermia-and-the-cooperative-action-of-mir-106b%C3%A2-25-and-mir-17%C3%A2-92-is-required-to-maintain-male-fertility
#11
JOURNAL ARTICLE
Alicia Hurtado, Rogelio Palomino, Ina Georg, Miguel Lao, Francisca M Real, F David Carmona, Miguel Burgos, Rafael Jiménez, Francisco J Barrionuevo
The identification of new genes involved in sexual development and gonadal function as potential candidates causing male infertility is important for both diagnostic and therapeutic purposes. Deficiency of the onco-miRNA cluster miR-17∼92 has been shown to disrupt spermatogenesis, whereas mutations in its paralog cluster, miR-106b∼25, that is expressed in the same cells, were reported to have no effect on testis development and function. The aim of this work is to determine the role of these two miRNA clusters in spermatogenesis and male fertility...
June 1, 2020: Molecular Human Reproduction
https://read.qxmd.com/read/32327618/circulation-of-human-papillomavirus-and-chlamydia-trachomatisin-cuban-women
#12
JOURNAL ARTICLE
Elías Guilarte-García, Yudira Soto-Brito, Vivian Kourí-Cardellá, Celia Maria Limia-León, Maria de Lourdes Sánchez-Alvarez, Ana Elisa Rodríguez-Díaz, Ledy X López-Fuentes, Melisa Méndez-González, Nancy Aróstica-Valdés, Marlevis Bello-Pérez, Lissette Pérez-Santos, Yanet Pintos-Saavedra, Yoanna Baños-Morales
INTRODUCTION Human papillomaviruses and Chlamydia tracho-matis are the most frequent causes of sexually transmitted infec-tions. Although the association between some human papillomavirus genotypes and cervical cancer has been demonstrated and Chla-mydia trachomatis infection is the most common cause of female infertility, Cuba has no national baseline studies on the circulation and co-circulation of these agents, the synergistic effect of which may be a risk factor for occurrence and development of precancer-ous cervical lesions...
January 2020: MEDICC Review
https://read.qxmd.com/read/32074269/the-role-of-micrornas-in-ovarian-function-and-the-transition-toward-novel-therapeutic-strategies-in-fertility-preservation-from-bench-to-future-clinical-application
#13
JOURNAL ARTICLE
C Alexandri, A Daniel, G Bruylants, I Demeestere
BACKGROUND: New therapeutic approaches in oncology have converted cancer from a certain death sentence to a chronic disease. However, there are still challenges to be overcome regarding the off-target toxicity of many of these treatments. Oncological therapies can lead to future infertility in women. Given this negative impact on long-term quality of life, fertility preservation is highly recommended. While gamete and ovarian tissue cryopreservation are the usual methods offered, new pharmacological-based options aiming to reduce ovarian damage during oncological treatment are very attractive...
February 28, 2020: Human Reproduction Update
https://read.qxmd.com/read/29920910/fertility-managment-in-testicular-cancer-the-need-to-establish-a-standardized-and-evidence-based-patient-centric-pathway
#14
REVIEW
Jemma A Moody, Kamran Ahmed, Tet Yap, Suks Minhas, Majid Shabbir
OBJECTIVES: The aim of the present paper was to determine the impact of testicular cancer (TC) and its treatments on fertility and to review the current management options for the infertile patient with TC, both before diagnosis and after treatment, with the aim of providing practical recommendations to update contemporary guidelines and standardize clinical practice. PATIENTS AND METHODS: Searches were conducted for relevant articles on Pubmed and Google Scholar between 2000 and 2017, with additional articles sourced from reference lists of included publications...
January 2019: BJU International
https://read.qxmd.com/read/28511670/onco-testicular-sperm-extraction-onco-tese-for-bilateral-testicular-tumors-two-case-reports
#15
JOURNAL ARTICLE
Sohgo Tsutsumi, Takashi Kawahara, Teppei Takeshima, Sawako Chiba, Koichi Uemura, Masako Otani, Kota Shimokihara, Yutaro Hayashi, Taku Mochizuki, Daiji Takamoto, Yusuke Hattori, Jun-Ichi Teranishi, Yasuhide Miyoshi, Masahiro Yao, Yoshiaki Inayama, Yasushi Yumura, Hiroji Uemura
BACKGROUND: Most patients with testicular cancer are infertile; thus, the preservation of the sperm after surgery is an important factor to consider. We report two cases of bilateral testicular cancer in patients who underwent bilateral higher orchiectomy and simultaneous testicular sperm extraction. CASE PRESENTATION: Two Asian-Japanese men were referred to our hospital with bilateral testicular tumors. Both of the patients were preoperatively diagnosed with azoospermia and requested testicular sperm extraction at the time of higher orchiectomy...
May 17, 2017: Journal of Medical Case Reports
https://read.qxmd.com/read/27887012/epididymal-papillary-cystadenocarcinoma-metastasising-to-the-testis-in-a-patient-with-infertility-managed-with-onco-microtese
#16
Nisha Pindoria, Yurina Miki, Andrea Tay, Ashish Chandra, Christopher Anderson, Evangelos Zacharakis, Majed Shabbir
Papillary cystadenomas of the epididymis are known to occur in association with Von Hippel-Lindau (VHL) disease. The development of a papillary cystadenocarcinoma, its malignant counterpart, is rare with only a few sporadic cases reported in the literature. Metastatic deposits are exceedingly uncommon; in fact, only a single case report has documented metastases to the paraureteral region, but metastases to the testis have never been reported. A 43-year-old gentleman with VHL disease presented with non-obstructive azoospermia, a right epididymal mass, and an atrophic surgically corrected undescended left testis...
November 24, 2016: Journal of Surgical Case Reports
https://read.qxmd.com/read/27255351/-current-situation-on-fertility-preservation-in-cancer-patients-in-spain-level-of-knowledge-information-and-professional-involvement
#17
JOURNAL ARTICLE
Carmen Garrido-Colino, Alvaro Lassaletta, María Ángeles Vazquez, Aizpea Echevarria, Ignacio Gutierrez, Maitane Andión, Pablo Berlanga
INTRODUCTION: The estimated risks of infertility in childhood cancer due to radiation, chemotherapy and surgery are well known. The involvement of professionals and advances in the different methods of preservation are increasing. However, many patients do not receive information or perform any method of preservation. MATERIAL: Questionnaires to paediatric onco-haematology institutions throughout Spain. The questionnaire consisted of 22 questions assessing their usual practices and knowledge about fertility preservation...
July 2017: Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría (A.E.P.)
https://read.qxmd.com/read/24846759/onco-testicular-sperm-extraction-birth-of-a-healthy-baby-after-fertility-preservation-in-synchronous-bilateral-testicular-cancer-and-azoospermia
#18
JOURNAL ARTICLE
M Roque, M Sampaio, P G de Oliveira Salles, S Geber
Testicular germ cell tumours (TGCT) represent 1%-1.5% of all male neoplasms, and they have the highest prevalence among men between 15 and 35 years old. Synchronous bilateral disease is a rare presentation, and the ratio of metachronous to synchronous bilateral disease is about 4 : 1. Several studies have suggested a correlation between male infertility and testicular cancer, with a 20-fold increase in the incidence of testicular cancer in infertile patients compared with the general population...
May 2015: Andrologia
https://read.qxmd.com/read/23417355/ovarian-stimulation-protocols-for-onco-fertility-patients
#19
JOURNAL ARTICLE
Juliette Koch, William Ledger
PURPOSE: To review options for ovarian stimulation before oocyte collection for fertility preservation for women with cancer or related diseases who require potentially sterilizing chemo- or radiotherapy. METHODS: Narrative review of current practice. RESULTS: Vitrification of oocytes and embryos has improved chances of pregnancy for this group of patients in recent years, increasing the uptake of fertility preservation before cancer treatment substantially...
February 2013: Journal of Assisted Reproduction and Genetics
https://read.qxmd.com/read/22690948/onco-testicular-sperm-extraction-testicular-sperm-extraction-in-azoospermic-and-very-severely-oligozoospermic-cancer-patients
#20
JOURNAL ARTICLE
K Furuhashi, T Ishikawa, H Hashimoto, S Yamada, S Ogata, Y Mizusawa, Y Matsumoto, E Okamoto, S Kokeguchi, M Shiotani
An increased risk of testicular cancer in men with infertility and poor semen quality has been reported. In view of the high cure rates for testicular germ cell tumours, increasing clinical importance is being placed on the protection of fertility. High-dose cytostatic therapy may be expected to cause long-term infertility. Thus, the standard procedure for fertility protection is the cryopreservation of ejaculated spermatozoa or testicular tissue before therapy. Four male patients with azoospermia and two patients with very severe oligozoospermia underwent onco-testicular sperm extraction (TESE)...
April 2013: Andrologia
keyword
keyword
27300
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.